Sergliflozin A
CAS No. 360775-96-8
Sergliflozin A( —— )
Catalog No. M36251 CAS No. 360775-96-8
Sergliflozin A is a selective SGLT2 inhibitor that induces diabetes in a dose-dependent manner. It reduces hyperglycemia.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 247 | In Stock |
|
| 10MG | 371 | In Stock |
|
| 25MG | 620 | In Stock |
|
| 50MG | 863 | In Stock |
|
| 100MG | 1172 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 2353 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSergliflozin A
-
NoteResearch use only, not for human use.
-
Brief DescriptionSergliflozin A is a selective SGLT2 inhibitor that induces diabetes in a dose-dependent manner. It reduces hyperglycemia.
-
DescriptionSergliflozin A is a selective SGLT2 inhibitor that induces diabetes in a dose-dependent manner. It reduces hyperglycemia.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetSGLT
-
RecptorSGLT
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number360775-96-8
-
Formula Weight376.4
-
Molecular FormulaC20H24O7
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO(C1=C(CC2=CC=C(OC)C=C2)C=CC=C1)[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Bexagliflozin
A potent and selective SGLT2 inhibitor with IC50 of 2 nM; shows little activity for SGLT1 (IC50=5.6 uM).
-
Canagliflozin
A highly potent and selective SGLT2 inhibitor with IC50 of 4.4, 3.7 and 2.0 nM for hSGLT2, rSGLT2 and mSGLT2, respectively.
-
Mizagliflozin
Mizagliflozin (DSP-3235, KGA-3235, GSK-1614235)?is a potent, selective, orally active SGLT1 inhibitor with Ki of 27 nM, displays >350-fold selectivity over SGLT2.
Cart
sales@molnova.com